• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植后巨细胞病毒疾病:准确诊断的线索

Cytomegalovirus disease after kidney transplantation: clues to accurate diagnosis.

作者信息

Nemati E, Eizadi M, Lankarani M Moghani, Kardavani B, Khoddami-Vishteh H-R, Kalantar E, Lesan-Pezeshki M, Khedmat H, Saadat A R

机构信息

Nephrology/Urology Research Center (NURC), Baqiyatallah Medical Sciences University, Tehran, Iran.

出版信息

Transplant Proc. 2007 May;39(4):987-9. doi: 10.1016/j.transproceed.2007.03.087.

DOI:10.1016/j.transproceed.2007.03.087
PMID:17524870
Abstract

BACKGROUND

The clinical diagnosis of cytomegalovirus (CMV) disease after kidney transplantation is often not accurate. We evaluated the factors associated with a correct diagnosis of CMV disease in these patients.

MATERIALS AND METHODS

This retrospective study of all renal transplant patients between 2004 and 2005 with a clinical diagnosis of CMV disease included both donors and recipients who were seropositive for CMV at transplantation. We assessed the rate and correlated factors with a correct diagnosis.

RESULTS

Among 127 cases, the 30 (23.6%) patients who had a correct diagnosis of CMV disease. Showed higher ages at transplantation (48.8 +/- 15.3 vs. 39.8 +/- 14.4 years; P=.004) and a shorter interval between transplantation and symptom presentation (9.7 +/- 20.7 vs. 25.6 +/- 33.6 days; P=.048). Diabetes mellitus (DM) was the cause of end-stage renal disease (ESRD) in 41% of patients with a correct diagnosis, whereas it was the cause in 11% of CMV disease-negative patients (P<.001). A multiple logistic regression model showed that DM as the cause of ESRD (P=.001; odds ratio [OR] 16.331), >5 months duration between transplantation and the presence of symptoms (P=.001; OR, 0.060), and age at transplantation >55 years (P=.022; OR, 3.833) were predictors of a correct diagnosis of CMV disease (chi(2)=46.45; P<.001).

CONCLUSION

The results herein showed that considering some variables significantly improved the accuracy of a correct diagnosis of CMV disease after kidney transplantation.

摘要

背景

肾移植后巨细胞病毒(CMV)疾病的临床诊断往往不准确。我们评估了这些患者中与CMV疾病正确诊断相关的因素。

材料与方法

这项对2004年至2005年间所有临床诊断为CMV疾病的肾移植患者的回顾性研究,包括移植时CMV血清学阳性的供体和受体。我们评估了正确诊断的发生率及其相关因素。

结果

在127例病例中,30例(23.6%)患者被正确诊断为CMV疾病。这些患者移植时年龄较大(48.8±15.3岁对39.8±14.4岁;P = 0.004),移植与症状出现之间的间隔较短(9.7±20.7天对25.6±33.6天;P = 0.048)。在正确诊断的患者中,41%的患者终末期肾病(ESRD)的病因是糖尿病(DM),而在CMV疾病阴性的患者中这一比例为11%(P<0.001)。多因素逻辑回归模型显示,ESRD病因是DM(P = 0.001;比值比[OR]16.331)、移植与症状出现之间的持续时间>5个月(P = 0.001;OR,0.060)以及移植时年龄>55岁(P = 0.022;OR,3.833)是CMV疾病正确诊断的预测因素(χ2=46.45;P<0.001)。

结论

本文结果表明,考虑一些变量可显著提高肾移植后CMV疾病正确诊断的准确性。

相似文献

1
Cytomegalovirus disease after kidney transplantation: clues to accurate diagnosis.肾移植后巨细胞病毒疾病:准确诊断的线索
Transplant Proc. 2007 May;39(4):987-9. doi: 10.1016/j.transproceed.2007.03.087.
2
Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.巨细胞病毒复制及“疱疹病毒负荷”作为肾移植术后第一年心血管事件的危险因素
Transplant Proc. 2005 Nov;37(9):3760-3. doi: 10.1016/j.transproceed.2005.08.058.
3
Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease.终末期肾病患者巨细胞病毒血清阳性与动脉粥样硬化疾病密切相关。
Nephrol Dial Transplant. 2007 Nov;22(11):3298-303. doi: 10.1093/ndt/gfm348. Epub 2007 Jun 27.
4
Signs and symptoms of cytomegalovirus disease in kidney transplant recipients.肾移植受者巨细胞病毒病的体征和症状。
Transplant Proc. 2005 Sep;37(7):3056-8. doi: 10.1016/j.transproceed.2005.07.051.
5
The association between cytomegalovirus infection and atherosclerotic events in renal transplant recipients.肾移植受者中巨细胞病毒感染与动脉粥样硬化事件之间的关联。
Transplant Proc. 2007 May;39(4):990-2. doi: 10.1016/j.transproceed.2007.02.026.
6
Clinical manifestation, laboratory findings, and the response of treatment in kidney transplant recipients with CMV infection.肾移植受者巨细胞病毒感染的临床表现、实验室检查结果及治疗反应
Transplant Proc. 2007 May;39(4):993-6. doi: 10.1016/j.transproceed.2007.02.014.
7
Pre-transplant predictors of cerebrovascular events after kidney transplantation.肾移植后脑血管事件的移植前预测因素。
Nephrol Dial Transplant. 2008 Apr;23(4):1429-35. doi: 10.1093/ndt/gfm766. Epub 2007 Nov 28.
8
Cytomegalovirus infection of the graft duodenum and urinary bladder after simultaneous pancreas-kidney transplantation.胰肾联合移植术后移植十二指肠和膀胱的巨细胞病毒感染
Transplant Proc. 2004 Sep;36(7):2200-2. doi: 10.1016/j.transproceed.2004.08.120.
9
Influence of cytomegalovirus disease on early and late renal graft function.
Transplant Proc. 2006 Jan-Feb;38(1):147-50. doi: 10.1016/j.transproceed.2005.12.024.
10
Gancyclovir prophylaxis in high risk patients.对高危患者进行更昔洛韦预防治疗。
Transplant Proc. 2005 Dec;37(10):4311-2. doi: 10.1016/j.transproceed.2005.10.125.

引用本文的文献

1
Incidence and risk factors for cytomegalovirus in kidney transplant patients in Babol, northern Iran.伊朗北部巴博勒肾移植患者巨细胞病毒的发病率及危险因素
Caspian J Intern Med. 2017 Winter;8(1):23-29.
2
Cytomegalovirus disease in renal transplant recipients: a single-center experience.肾移植受者巨细胞病毒病:单中心经验。
Indian J Microbiol. 2012 Sep;52(3):510-5. doi: 10.1007/s12088-012-0268-9. Epub 2012 Apr 4.